p38 MAP kinase modulates liver cell volume through inhibition of membrane Na+ permeability

Andrew P. Feranchak, Tomas Berl, Juan Capasso, Paul A. Wojtaszek, Jiahuai Han, J. Gregory Fitz

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

In hepatocytes, Na+ influx through nonselective cation (NSC) channels represents a key point for regulation of cell volume. Under basal conditions, channels are closed, but both physiologic and pathologic stimuli lead to a large increase in Na+ and water influx. Since osmotic stimuli also activate mitogen-activated protein (MAP) kinase pathways, we have examined regulation of Na+ permeability and cell volume by MAP kinases in an HTC liver cell model. Under isotonic conditions, there was constitutive activity of p38 MAP kinase that was selectively inhibited by SB203580. Decreases in cell volume caused by hypertonic exposure had no effect on p38, but increases in cell volume caused by hypotonic exposure increased p38 activity tenfold. Na+ currents were small when cells were in isotonic media but could be increased by inhibiting constitutive p38 MAP kinase, thereby increasing cell volume. To evaluate the potential inhibitory role of p38 more directly, cells were dialyzed with recombinant p38α and its upstream activator, MEK-6, which substantially inhibited volume-sensitive currents. These findings indicate that constitutive p38 activity contributes to the low Na+ permeability necessary for maintenance of cell volume, and that recombinant p38 negatively modulates the set point for volume-sensitive channel opening. Thus, functional interactions between p38 MAP kinase and ion channels may represent an important target for modifying volume-sensitive liver functions.

Original languageEnglish (US)
Pages (from-to)1495-1504
Number of pages10
JournalJournal of Clinical Investigation
Volume108
Issue number10
DOIs
StatePublished - 2001

Fingerprint

p38 Mitogen-Activated Protein Kinases
Cell Size
Permeability
Membranes
Liver
Mitogen-Activated Protein Kinases
Mitogen-Activated Protein Kinase Kinases
Ion Channels
Cations
Hepatocytes
Maintenance
Water

ASJC Scopus subject areas

  • Medicine(all)

Cite this

p38 MAP kinase modulates liver cell volume through inhibition of membrane Na+ permeability. / Feranchak, Andrew P.; Berl, Tomas; Capasso, Juan; Wojtaszek, Paul A.; Han, Jiahuai; Fitz, J. Gregory.

In: Journal of Clinical Investigation, Vol. 108, No. 10, 2001, p. 1495-1504.

Research output: Contribution to journalArticle

Feranchak, Andrew P. ; Berl, Tomas ; Capasso, Juan ; Wojtaszek, Paul A. ; Han, Jiahuai ; Fitz, J. Gregory. / p38 MAP kinase modulates liver cell volume through inhibition of membrane Na+ permeability. In: Journal of Clinical Investigation. 2001 ; Vol. 108, No. 10. pp. 1495-1504.
@article{652c5539dd86480299b42fcdbfab03ce,
title = "p38 MAP kinase modulates liver cell volume through inhibition of membrane Na+ permeability",
abstract = "In hepatocytes, Na+ influx through nonselective cation (NSC) channels represents a key point for regulation of cell volume. Under basal conditions, channels are closed, but both physiologic and pathologic stimuli lead to a large increase in Na+ and water influx. Since osmotic stimuli also activate mitogen-activated protein (MAP) kinase pathways, we have examined regulation of Na+ permeability and cell volume by MAP kinases in an HTC liver cell model. Under isotonic conditions, there was constitutive activity of p38 MAP kinase that was selectively inhibited by SB203580. Decreases in cell volume caused by hypertonic exposure had no effect on p38, but increases in cell volume caused by hypotonic exposure increased p38 activity tenfold. Na+ currents were small when cells were in isotonic media but could be increased by inhibiting constitutive p38 MAP kinase, thereby increasing cell volume. To evaluate the potential inhibitory role of p38 more directly, cells were dialyzed with recombinant p38α and its upstream activator, MEK-6, which substantially inhibited volume-sensitive currents. These findings indicate that constitutive p38 activity contributes to the low Na+ permeability necessary for maintenance of cell volume, and that recombinant p38 negatively modulates the set point for volume-sensitive channel opening. Thus, functional interactions between p38 MAP kinase and ion channels may represent an important target for modifying volume-sensitive liver functions.",
author = "Feranchak, {Andrew P.} and Tomas Berl and Juan Capasso and Wojtaszek, {Paul A.} and Jiahuai Han and Fitz, {J. Gregory}",
year = "2001",
doi = "10.1172/JCI200112190",
language = "English (US)",
volume = "108",
pages = "1495--1504",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "10",

}

TY - JOUR

T1 - p38 MAP kinase modulates liver cell volume through inhibition of membrane Na+ permeability

AU - Feranchak, Andrew P.

AU - Berl, Tomas

AU - Capasso, Juan

AU - Wojtaszek, Paul A.

AU - Han, Jiahuai

AU - Fitz, J. Gregory

PY - 2001

Y1 - 2001

N2 - In hepatocytes, Na+ influx through nonselective cation (NSC) channels represents a key point for regulation of cell volume. Under basal conditions, channels are closed, but both physiologic and pathologic stimuli lead to a large increase in Na+ and water influx. Since osmotic stimuli also activate mitogen-activated protein (MAP) kinase pathways, we have examined regulation of Na+ permeability and cell volume by MAP kinases in an HTC liver cell model. Under isotonic conditions, there was constitutive activity of p38 MAP kinase that was selectively inhibited by SB203580. Decreases in cell volume caused by hypertonic exposure had no effect on p38, but increases in cell volume caused by hypotonic exposure increased p38 activity tenfold. Na+ currents were small when cells were in isotonic media but could be increased by inhibiting constitutive p38 MAP kinase, thereby increasing cell volume. To evaluate the potential inhibitory role of p38 more directly, cells were dialyzed with recombinant p38α and its upstream activator, MEK-6, which substantially inhibited volume-sensitive currents. These findings indicate that constitutive p38 activity contributes to the low Na+ permeability necessary for maintenance of cell volume, and that recombinant p38 negatively modulates the set point for volume-sensitive channel opening. Thus, functional interactions between p38 MAP kinase and ion channels may represent an important target for modifying volume-sensitive liver functions.

AB - In hepatocytes, Na+ influx through nonselective cation (NSC) channels represents a key point for regulation of cell volume. Under basal conditions, channels are closed, but both physiologic and pathologic stimuli lead to a large increase in Na+ and water influx. Since osmotic stimuli also activate mitogen-activated protein (MAP) kinase pathways, we have examined regulation of Na+ permeability and cell volume by MAP kinases in an HTC liver cell model. Under isotonic conditions, there was constitutive activity of p38 MAP kinase that was selectively inhibited by SB203580. Decreases in cell volume caused by hypertonic exposure had no effect on p38, but increases in cell volume caused by hypotonic exposure increased p38 activity tenfold. Na+ currents were small when cells were in isotonic media but could be increased by inhibiting constitutive p38 MAP kinase, thereby increasing cell volume. To evaluate the potential inhibitory role of p38 more directly, cells were dialyzed with recombinant p38α and its upstream activator, MEK-6, which substantially inhibited volume-sensitive currents. These findings indicate that constitutive p38 activity contributes to the low Na+ permeability necessary for maintenance of cell volume, and that recombinant p38 negatively modulates the set point for volume-sensitive channel opening. Thus, functional interactions between p38 MAP kinase and ion channels may represent an important target for modifying volume-sensitive liver functions.

UR - http://www.scopus.com/inward/record.url?scp=0035187004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035187004&partnerID=8YFLogxK

U2 - 10.1172/JCI200112190

DO - 10.1172/JCI200112190

M3 - Article

C2 - 11714741

AN - SCOPUS:0035187004

VL - 108

SP - 1495

EP - 1504

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 10

ER -